Pharmabiz

DoP in association with FICCI & IP Alliance to organise 9th edition of India Pharma 2026 on April 13 & 14 in New Delhi

DoP in association with FICCI & IP Alliance to organise 9th edition of India Pharma 2026 on April 13 & 14 in New Delhi: Our Bureau, New Delhi Monday, April 6, 2026, 09:00 Hrs [IST ...
Pharmabiz

TNCDA files complaint against Tata 1MG for drug law violations, joins AIOCD’s call for national bandh

TNCDA files complaint against Tata 1MG for drug law violations, joins AIOCD’s call for national bandh: Peethaambaran Kunnathoor, Chennai Monday, April 6, 2026, 08:00 Hrs [IST] T ...
Pharmabiz

Recent advances in genetics to identify DNA changes directly linked to cancer development in CRC

Recent advances in genetics to identify DNA changes directly linked to cancer development in CRC: Shardul Nautiyal, Mumbai Monday, April 6, 2026, 08:00 Hrs [IST] Recent advances i ...
Pharmabiz

Parliamentary Panel asks DoP to address issues in RPTUAS for fund utilisation

Parliamentary Panel asks DoP to address issues in RPTUAS for fund utilisation: Gireesh Babu, New Delhi Monday, April 6, 2026, 08:00 Hrs [IST] Taking note that no actual expenditur ...
Pharmabiz

DTAB recommends revision of microbial contamination limits in Schedule M

DTAB recommends revision of microbial contamination limits in Schedule M: Gireesh Babu, New Delhi Monday, April 6, 2026, 08:00 Hrs [IST] The Drugs Technical Advisory Board has agr ...
Pharmabiz

KCDA opposes mandatory geo-tagging of pharmacy outlets, cites lack of legal backing

KCDA opposes mandatory geo-tagging of pharmacy outlets, cites lack of legal backing: Nandita Vijayasimha, Bengaluru Monday, April 6, 2026, 08:00 Hrs [IST] The Karnataka Chemists & ...
PharmabizOpinion

KPRDO concerned over escalating conflict in West Asia impacting pharmacy trade

KPRDO concerned over escalating conflict in West Asia impacting pharmacy trade: Nandita Vijayasimha, Bengaluru Monday, April ...
Pharmabiz

Merck’s Keytruda plus paclitaxel ± bevacizumab gets EU approval to treat adults with PD-L1 platinum-resistant recurrent ovarian carcinoma who have received one or two prior ...

Merck’s Keytruda plus paclitaxel ± bevacizumab gets EU approval to treat adults with PD-L1 platinum-resistant recurrent ovarian carcinoma who have received one or two prior systemic treatment regimens ...
Pharmabiz

Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back

Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back: Nottingham, UK Saturday, April 4, 2026, 18:00 Hrs [IST] Sygnature Discovery, a le ...
Pharmabiz

Biocytogen and Sihuan Pharmaceutical enter strategic partnership in weight loss and beyond

Biocytogen and Sihuan Pharmaceutical enter strategic partnership in weight loss and beyond: Waltham, Massachusetts Saturday, April 4, 2026, 16:00 Hrs [IST] Biocytogen Pharmaceutic ...
Pharmabiz

Symbiosis Pharmaceutical Services expands commercial capabilities with addition of new stability chamber

Symbiosis Pharmaceutical Services expands commercial capabilities with addition of new stability chamber: Stirling, UK Saturday, April 4, 2026, 17:00 Hrs [IST] Symbiosis Pharmaceu ...
Pharmabiz

Merck initiates pivotal phase 2b/3 trial of Tiespectus, an investigational bispecific tie2 agonist/VEGF inhibitor, to treat neovascular age-related macular degeneration

Merck initiates pivotal phase 2b/3 trial of Tiespectus, an investigational bispecific tie2 agonist/VEGF inhibitor, to treat neovascular age-related macular degeneration: Rahway, N ...